Related Experiment Video
Updated: Jun 23, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Corticosteroids and HIV infection: a review of experience
1PPD, Washington, District of Columbia, USA.
Purpose Of Review:
Apoptosis caused by immune activation is thought to be an important mechanism for progressive CD4 T-cell depletion in HIV disease. This review examines published literature on the effects of corticosteroids on activation markers and disease indicators in HIV.
Recent Findings:
Salutary effects were noted on activation markers, apoptosis and circulating CD4 T-cell numbers in studies in which corticosteroids were administered together with antiretroviral therapy. Safety concerns regarding osteonecrosis of the hip have limited further research in this area. Controlled trials in which corticosteroids were administered in the absence of antiretroviral therapy have generally not shown a clinical benefit to this treatment.
Summary:
These studies may indicate a potential role for deactivating strategies in the management of HIV infection. Targeted therapies with superior long-term safety profiles will be required for this concept to advance further in clinical trials.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis
Retrovirus Life Cycles
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
